The Biomarkers of Aging Consortium is proud to announce its second annual Biomarkers of Aging Conference, scheduled for November 1-2, 2024, at the Joseph Martin Conference Center at Harvard Medical School. This event stands as the premier conference dedicated to all aspects of biomarkers of aging, bringing together the brightest minds in the field.
Building on the success of its inaugural event, the 2024 conference has been expanded in both length and scope to accommodate the rapidly evolving landscape of aging research. The two-day format will offer attendees a comprehensive exploration of the latest developments in the field:
- Day 1: Cutting-Edge Research – Focused on the latest breakthroughs and emerging technologies in biomarkers of aging.
- Day 2: Clinical Translation – Dedicated to bridging the gap between laboratory findings and practical applications in healthcare.
The conference boasts a stellar lineup of speakers, featuring renowned experts from across the globe. Attendees can expect engaging presentations, panel discussions, and networking opportunities with the foremost authorities in aging research.
- Key highlights of the conference include:
- Talks from pioneering researchers in the field
- Panel discussions on the future of aging biomarkers in medicine
- Poster sessions showcasing emerging research from early-career scientists
- Networking opportunities to foster collaboration and partnership opportunities
Registration for the 2024 Biomarkers of Aging Conference is now open. For more information on the conference program, registration details, and sponsorship opportunities, please visit https://www.agingconsortium.org/conference-2024.
About the Biomarkers of Aging Consortium: We are a consortium of scholars and practitioners developing, validating, and implementing biomarkers of aging and longevity. Our academic members are affiliated with the leading research institutes and groups in the field of aging. Our practitioners are at the forefront of research and development in the longevity industry.
Contact: Nicholas Fiorenza [email protected]